Cell surface expression of urokinase receptor in normal mammary epithelial cells and breast cancer cell lines

Anticancer Research

Volumn 19, Issue 2 A, 1999, Pages 1223-1228

  Li, Yonghe ^a,b   Wood, Nick ^a   Yellowlees, David ^b   Donnelly, Peter K ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b JAMES COOK UNIVERSITY   (Australia)

Author keywords

Breast cancer; Flow cytometry; Mammary epithelial cells; uPAR expression

Indexed keywords

UROKINASE RECEPTOR;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL CULTURE; CANCER INVASION; CELL SURFACE; CONTROLLED STUDY; DEGRADATION; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BREAST; BREAST NEOPLASMS; EPITHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKOCYTES, MONONUCLEAR; MICE; RECEPTORS, CELL SURFACE; TUMOR CELLS, CULTURED;

EID: 0032991338     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Andreasen PA, Kjoller L, Christensen L, Duffy MJ: The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 72: 1-22, 1997.
2. Ellis V, Scully MF, Kakkar VV: Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes. J Biol Chem 264: 2185-2188, 1989.
3. Ellis V, Behrendt N, Dano K: Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor. J Biol Chem 266: 12752-12758, 1991.
4. Conese M, Nykjaer A, Petersen CM, Cremona O, Pardi R, Andreasen PA, Gliemann J, Christensen EI, Blasi F: α2-Macroglobulin receptor/Ldl receptor-related protein (Lrp)-dependent internalization of the urokinase receptor. J Cell Biol 131: 1609-1622, 1995.
5. Nykjaer A, Conese M, Christensen EI, Olson D, Cremona O, Gliemann J, Blasi F: Recycling of the urokinase receptor upon internalization of the uPA: serpin complexes. EMB O J 16: 2610-2620, 1997.
6. Del Vecchio S, Stoppelli MP, Carriero MV, Fonti R, Massa O, Li PY, Botti G, Cerra M, D'Aiuto G, Esposito G, Salvatore M: Human urokinase receptor concentration in malignant and benign breast tumours by in vitro quantitative autoradiography: comparison with urokinase levels. Cancer Res 53: 3198-3206, 1993.
7. Costantini V, Sidoni A, Deveglia R, Cazzato OA, Bellezza G, Ferri I, Bucciarelli E, Nenci GG: Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: an immunohistochemical comparison of normal, benign, and malignant breast tissues. Cancer 77: 1079-1088, 1996.
8. Sliutz G, Eder H, Koelbl H, Tempfer C, Auerbach L, Schneeberger C, Kainz C, Zeillinger R: Quantification of uPA receptor expression in human breast cancer cell lines by cRT-PCR. Breast Cancer Res Treat 40:257-263, 1996.
9. Xing RH, Rabbani SA: Overexpression of urokinase receptor in breast cancer cells results in increased tumour invasion, growth and metastasis. Int J Cancer 67: 423-429, 1996.
10. Albo D, Berger DH, Wang TN, Hu X, Rothman V, Tuszynski GP: Thrombospondin-1 and transforming growth factor-β1 promote breast tumour cell invasion through up-regulation of the plasminogen/plasmin system. Surgery 122: 493-499, 1997.
11. Holst-Hansen C, Johannessen B, Hoyer-Hansen G, Romer J, Ellis V, Brunner N: Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness. Clin Exp Metastasis 14: 297-307, 1996.
12. Nguyen DHD, Hussaini IM, Gonias SL: Binding of urokinase-type plasminogen activator to its receptor in MCF-7 cells activates extracellular signal-regulated kinase 1 and 2 which is required cellular motility. J Biol Chem 273: 8502-8507, 1998.
13. Jankun J, Merrick HW, Goldblatt PJ: Expression and localisation of elements of the plasminogen activation system in benign breast disease and breast cancers. J Cell Biochem 53: 135-144, 1993.
14. Mohanam S, Sawaya R, McCutcheon I, Ali-Osman F, Boyd D, Rao JS: Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody. Cancer Res 53: 4143-4147, 1993.
15. Stahl A, Mueller BM: Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro. Cancer Res 54: 3066-3071, 1994.
16. Kirchheimer JC, Nong YH, Remold HG: IFN-γ, tumour necrosis factor-α, and urokinase regulate the expression of urokinase receptors on human monocytes. J Immunol 141: 4229-4234, 1988.
17. Jardi M, Ingles-Esteve J, Burgal M, Azqueta C, Velasco F, Lopez-Pedrera C, Miles LA, Felez J: Distinct patterns of urokinase receptor (uPAR) expression by leukemic cells and peripheral blood cells. Thromb Haemost 76: 1009-1019, 1997.
18. Chucholowski N, Schmitt M, Rettenburger P, Schuren E, Moniwa N, Goretzki L, Wilhelm O, Weidle U, Janicke F, Graeff H: Flow cytometric analysis of the urokinase receptor (uPAR) on tumour cells by fluorescent uPA-ligand or monoclonal antibody #3936. Fibrinolysis 6: 95-102, 1992.
19. Zagursky RJ, Sharp D, Solomon KA, Schwartz A Quantitation of cellular receptors by a new immunocytochemical flow cytometry technique. Biotechniques 18: 504-509, 1995.
20. Li Y, Wood N, Parsons PG, Yellowlees D, Donnelly PK: Expression of α2-macroglobulin receptor low density lipoprotein receptor-related protein on surfaces of tumour cells: a study using flow cytometry. Cancer Lett 111: 199-205, 1997.
21. Boyd D, Florent G, Kim P, Brattain M: Determination of the levels of urokinase and its receptor in human colon carcinoma cell lines. Cancer Res 48: 3112-3116, 1988.